Harrow, Inc. (HROW)
30.94
+0.26
(+0.85%)
USD |
NASDAQ |
May 20, 16:00
30.67
-0.27
(-0.87%)
After-Hours: 05:21
Harrow Profit Margin (Quarterly) : -62.44% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 37.36% |
| Esperion Therapeutics, Inc. | -31.45% |
| Theravance Biopharma, Inc. | -27.87% |
| Xeris Biopharma Holdings, Inc. | 2.69% |
| Aquestive Therapeutics, Inc. | -55.77% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -32.17% |
| Return on Assets | -3.94% |
| Return on Invested Capital | -4.99% |
| Gross Profit Margin (Quarterly) | 61.18% |
| Operating Margin (Quarterly) | -49.95% |
| Return on Net Operating Assets | -4.94% |